RCSB PDB - 1YY8: Crystal structure of the Fab fragment from the monoclonal antibody cetuximab/Erbitux/IMC-C225
Cetuximab: Uses, Interactions, Mechanism of Action | DrugBank Online
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose | NEJM
AAVrh.10-mediated expression of cetuximab. A. Design of the... | Download Scientific Diagram
Automated, Kit-Based Sample Preparation Strategy for LC-MS Quantification of Cetuximab in Rat Plasma | Waters
Frontiers | Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. - Abstract - Europe PMC
Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer - Hsu - 2019 - Cancer Medicine - Wiley Online Library
Schematic representation IdeS enzymatic cleavage of cetuximab.... | Download Scientific Diagram
Part:BBa K1694004 - parts.igem.org
A: Amino Acid Sequence of Cetuximab, heavy chain chain (Source:... | Download Scientific Diagram
Frontiers | The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
WO2014125382A2 - Cetuximab with modified glycosylation and uses thereof - Google Patents
From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway | PNAS
Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment
Amino acid sequence comparisons of the CDR regions for mAbs S25-26,... | Download Table
Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance | Nature Communications
RCSB PDB - 1YY8: Crystal structure of the Fab fragment from the monoclonal antibody cetuximab/Erbitux/IMC-C225
Schematic representation of trastuzumab and cetuximab. Blue parts of... | Download Scientific Diagram
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin | Scientific Reports
Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis - Jing - 2019 - Cancer Medicine - Wiley Online Library
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. - Abstract - Europe PMC
A: Amino Acid Sequence of Cetuximab, heavy chain chain (Source:... | Download Scientific Diagram
